A constant and interactive collaboration with medical experts and professionists in urinary incontinence is a important pillar of our approach. It allows continuous improvements of our products making it suitable for needs of the patients and professionists.

Benefits for physician

For the first time in this field, a unisex, minimally invasive endo-urethral medical device. It is inserted by the urologist in outpatient setting under local anesthesia by using a traditional resectoscope (26 Fr). The procedure requires between 15-30 minutes. The same procedure is adpoted for the removal procedure

The intellectual property of the device has been extensively protected and extended. The company obtained two long-term patents licenses, and it is the owner of two more patents on which the technology is based. Besides, a design patent and a trademark have been granted.

The key element of the device is a silicone valve that replaces the function of the biological external urinary sphincter. The device is activated when the patient contracts the abdomen. The valve is incorporated in a Titanium frame that has the function of ensuring the proper anchoring and stability of the device once inserted. The Nitinol stents collapse to allow the insertion of UroRelief. Once inserted, the valve is normally in a closed position. In this configuration, the device restores continence up to a physiological vesical pressure imposed by the valve. When a patient feels the urge to urinate, he or she applies vesical pressure by contracting the abdomen. The vesical pressure shall be above the valve opening pressure; in this way, the device opens allowing a physiological voiding flow. During the voiding, the valve opening pressure decreases its resistance, making the voiding flow more comfortable and as similar as possible to the physiological one. Once the urination has ended, as well as the pressure imposed by the patient, the device’s valve automatically closes restoring continence to the starting valve opening pressure.

The device benefits from an extremely simple and innovative design, without electronic components on board, being based on a passive solution. This will facilitate the certification phases and will maximize the acceptability and usability of the device, even by patients with limited psychomotor skills.